RECRUITING Not applicable ClinicalTrials.gov

Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment

Sponsor: Baker Heart and Diabetes Institute • ClinicalTrials.gov ID: NCT05558605

Registry updated: 2026-09-30

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

Heart Failure and valvular heart disease are disproportionate problems in rural and remote Australia (RRA). Echocardiography is the best imaging investigation, and essential for management, but access to this essential test shows huge geographic variations, primarily because of dependence on expert acquisition. This trial seeks to demonstrate the effectiveness of artificial intelligence-based echocardiography for triage and management of patients with known or suspected heart disease in RRA.

Interventions

AI-guided echo (Diagnostic test)
AI-guided echocardiography
Standard echo (Diagnostic test)
Standard echocardiography

Eligibility criteria

Inclusion Criteria: * Age \>45 years * eligible for Medicare * exercise intolerance or cardiovascular (CV) risk factors Exclusion Criteria: * Known HF or HVD * situations where cardio-protection is already indicated (eg. known CAD) * comorbid conditions with life expectancy \<2 years * inability to provide written informed consent

Conditions

Heart Failure Valve Heart Disease

Locations

Alice Springs Hospital — Alice Springs, Northern Territory, Australia

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment